Latest AI and machine learning research in dementia for healthcare professionals.
Alzheimer's is a degenerative brain cell disease that affects around 5.8 million people globally. Th...
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative disorder caused by a complex interplay o...
BACKGROUND: Computer-aided machine learning models are being actively developed with clinically avai...
BACKGROUND: In recent years, researchers have focused on developing precise models for the progressi...
OBJECTIVE: The increasing longevity of the population has made Alzheimer's disease (AD) a significan...
BACKGROUND: Dementia is a general term for several progressive neurodegenerative disorders including...
As the world's population ages, Alzheimer's disease is currently the seventh most common cause of de...
BACKGROUND: Alzheimer's disease (AD) is a recognized complex and severe neurodegenerative disorder, ...
BACKGROUND: Polygenic risk scores (PRS) are linear combinations of genetic markers weighted by effec...
With the advent of therapeutics with potential to slow Alzheimer's disease progression the necessity...
BACKGROUND: Primary outcome measure in the clinical trials of disease modifying therapy (DMT) drugs ...
BACKGROUND: There are various molecular hypotheses regarding Alzheimer's disease (AD) like amyloid d...
Alzheimer's disease (AD) is a chronic neurodegenerative disorder with a global impact. The past few ...
BACKGROUND: Long non-coding RNA (lncRNA) plays a crucial role in various biological processes, and m...
BACKGROUND: The growing number of older adults in recent decades has led to more prevalent geriatric...
BACKGROUND: The progressive cognitive decline, an integral component of Alzheimer's disease (AD), un...
BACKGROUND: Alzheimer's disease (AD), a major dementia cause, lacks effective treatment. MRI-based h...
OBJECTIVE: The objective of this study is to develop a more effective early detection system for Alz...
As one of the leading causes for dementia in the population, it is imperative that we discern exactl...
Background PET can be used for amyloid-tau-neurodegeneration (ATN) classification in Alzheimer disea...
OBJECTIVES: To evaluate caregiver opinions on the use of artificial intelligence (AI)-assisted medic...